Clinical Trial Update: Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hormone therapy in combination with intensity-modulated radiation therapy for metastatic prostate cancer, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-04-06